Active, not recruitingPhase 3NCT05572515
A Study Comparing Teclistamab Monotherapy Versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma
Studying Hinman syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Janssen Research & Development, LLC
- Principal Investigator
- Janssen Research & Development, LLC Clinical TrialJanssen Research & Development, LLC
- Intervention
- Teclistamab(drug)
- Enrollment
- 614 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2023 – 2031
Study locations (30)
- Alaska Oncology and Hematology LLC, Anchorage, Alaska, United States
- Banner MD Anderson Cancer Center, Gilbert, Arizona, United States
- Alta Bates Comprehensive Cancer Center, Berkeley, California, United States
- MemorialCare Long Beach Medical Center, Long Beach, California, United States
- University of California Irvine, Orange, California, United States
- PIH Health Hospital, Whittier, California, United States
- Rocky Mountain Cancer Centers, Aurora, Colorado, United States
- University of Connecticut, Farmington, Connecticut, United States
- University of Miami Sylvester Cancer Center, Miami, Florida, United States
- Orlando Health Cancer Institute, Orlando, Florida, United States
- Cleveland Clinic Florida, Weston, Florida, United States
- Mission Cancer Blood, Waukee, Iowa, United States
- East Jefferson General Hospital Bone Marrow Transport Clinic, Metairie, Louisiana, United States
- Walter Reed National Military Medical Center, Bethesda, Maryland, United States
- Maryland Oncology Hematology P A, Silver Spring, Maryland, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05572515 on ClinicalTrials.govOther trials for Hinman syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT07307274A Study of SYNT-101 to Test Safety, Tolerability and Pharmacodynamics of SYNT-101 in Healthy and Overweight AdultsSyntis Bio
- ACTIVE NOT RECRUITINGPHASE2NCT07281937A Study of Weekly Oral Ecnoglutide (VRB-101) in Participants Who Have Obesity or Overweight With Weight-Related ComorbiditiesVerdiva Bio Dev Limited
- ENROLLING BY INVITATIONNANCT07283107Trial to Evaluate the Impact of Various Behavioural Interventions to Increase Mammography Uptake Among Singaporean WomenNational University Hospital, Singapore
- RECRUITINGNANCT07268508Impact of a Pro-diversity Gut Microbiota Diet After a Bariatric Surgery on Gut Microbiota, Eating Behaviour and Sensory FunctionHospices Civils de Lyon
- RECRUITINGPHASE2NCT06927739Focused Orticumab Research for Treating Inflammation in Coronary ArteriesAbcentra
- RECRUITINGNANCT07054333Objective Measurement of Pain Regulation in Individuals Who Have Received Internet-delivered Exposure-based Cognitive Behavior TherapyKarolinska Institutet
- RECRUITINGPHASE4NCT07030517A Study to Assess Safety of Teclistamab in Indian Participants With Relapsed and Refractory Multiple MyelomaJohnson & Johnson Private Limited
- RECRUITINGPHASE2NCT06846320Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety DisorderAbbVie